Blue Jet Healthcare Limited (BLUEJET.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-77.2%

₹113.23

vs ₹495.95 price

Levered DCF

₹106.15

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
P/E	22.9×	47.79×	41.46×	44.79×	39.48×	51.8×	49.51×
P/B	4.17×	12.87×	8.03×	10.52×	13.75×	21.1×	35.6×
P/S	5.99×	14.16×	9.56×	9.98×	10.6×	14.51×	13.32×
EV / EBITDA	18.93×	34.16×	27.18×	29.26×	26.49×	33.24×	33.1×
Gross margin	43.7%	54.4%	54.8%	37.6%	43.8%	50.1%	60.9%
Operating margin	28.5%	34.9%	47.5%	27.3%	32.9%	60.8%	56.5%
Net margin	26.2%	29.6%	23.1%	22.3%	26.8%	28.0%	26.9%
Current ratio	4.21×	3.93×	3.43×	3.82×	3.14×	2.39×	1.87×
Debt / equity	0.03×	0.02×	0×	0.01×	0.04×	0.15×	0.39×
Interest coverage	43.29×	3,672.87×	2,094.55×	144.49×	67.4×	56.64×	0×
Dividend yield	0.4%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	8.4%	5.7%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Return on equity	18.2%	26.9%	19.4%	23.5%	34.8%	40.7%	71.9%
Return on invested capital	14.2%	23.2%	29.3%	20.9%	30.3%	55.8%	80.2%
Return on assets	15.1%	21.5%	15.5%	18.6%	25.5%	25.8%	38.6%
Free cash flow yield	0.0%	-0.2%	1.0%	1.1%	1.7%	1.1%	1.5%
Earnings yield	4.4%	2.1%	2.4%	2.2%	2.5%	1.9%	2.0%
Enterprise value	₹55.7B	₹144.9B	₹67.5B	₹71.1B	₹71.2B	₹71.6B	₹72.4B
Net debt / EBITDA	-0.36×	-0.24×	-0.16×	-0.24×	-0.2×	-0.04×	0.31×
Cash conversion cycle (days)	220	260	204	184	171	201	110